Lederer & Associates Investment Counsel’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Lederer & Associates Investment Counsel's LLY Position: Q2 2026 in Review
Lederer & Associates Investment Counsel held its Eli Lilly (LLY) position steady in Q2 2026 at 305 shares worth $366K. The position accounts for 0.24% of the portfolio, ranked #79.
Lederer & Associates Investment Counsel first reported a position in LLY in Q1 2021 and has held it in 11 quarters since. The position peaked at $2.15M in Q2 2025. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Lederer & Associates Investment Counsel held 305 shares of Eli Lilly worth $366K as of Q2 2026.
- Lederer & Associates Investment Counsel left its Eli Lilly share count unchanged in Q2 2026.
- Eli Lilly made up 0.24% of Lederer & Associates Investment Counsel's portfolio in Q2 2026, its #79 holding.
- Lederer & Associates Investment Counsel first reported a position in Eli Lilly in Q1 2021 and has held it in 11 quarters since.
- Lederer & Associates Investment Counsel's Eli Lilly position peaked at $2.15M in Q2 2025.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Lederer & Associates Investment Counsel's 13F filing for Q2 2026, filed 10 Jul 2026.